Use of Orthobiologics to Improve Hip Pain and Function Among Patient with Various Pathoanatomic Diagnoses

Principal Investigator:

Dr. John Ferrell III

MD, Pennsylvania State College of Medicine

Dr. John Ferrell III is co-founder and managing partner of ROSM.  He is a board-certified Family Medicine Physician with fellowship training in Sports Medicine and Musculoskeletal Sonography.  His primary focus is on non-surgical management of orthopedic problems using regenerative approaches such as Microfragmented Adipose (MFAT), Bone Marrow Aspirate Concentrate (BMAC), Platelet Rich Plasma (PRP), Prolotherapy, and Tenex.

Study Abstract:

This Circle is one of six ROSM Circles focused on anatomical regions.  This multi-centric study aggregates real-world data focused on the application of orthobiologics for the hip, contributing to the evidence-based standardization of effectiveness and safety of PRP injections.  The Circle further allows members to aggregate, analyze and benchmark their de-identified data, helping to derive clinical evidence to inform their clinical decision-making.

Study Type:

Interventional

Circle Benefits:
  • Longitudinal, real-world safety and efficacy assessment of PRP.
  • Collaboration with nationally recognized musculoskeletal physicians.
  • Clinically significant registry datasets supporting standards of care for a variety of hip related pathologies.
Real-World Data Surveys:

HOOS

Circle Type:
locked lock icon for private circles

Private Circle

Interested in learning more about this Circle?

Related Posts

No items found.
Additional Resources:

Use of Orthobiologics to Improve Hip Pain and Function Among Patient with Various Pathoanatomic Diagnoses

Circle Objective Abstract:

This Circle is one of six ROSM Circles focused on anatomical regions.  This multi-centric study aggregates real-world data focused on the application of orthobiologics for the hip, contributing to the evidence-based standardization of effectiveness and safety of PRP injections.  The Circle further allows members to aggregate, analyze and benchmark their de-identified data, helping to derive clinical evidence to inform their clinical decision-making.

Real-World Data Surveys:

HOOS

Intervention:

Circle Benefits:
  • Longitudinal, real-world safety and efficacy assessment of PRP.
  • Collaboration with nationally recognized musculoskeletal physicians.
  • Clinically significant registry datasets supporting standards of care for a variety of hip related pathologies.

Streamlined patient enrollment, real-world data capturing, heightened recognition, prominence and collaboration

Circle Type:
locked lock icon for private circles

Private Circle

Supporting Materials
Interested in learning more about this Circle?

CIRCLE LIBRARY

CIRCLE NAME

Total Knee Arthroplasty Outcome-Based Performance Measure

SURVEYS

OUTCOMES SURVEYS

VAS
KOOS Jr.
VR-12 (compliant with CMS/IQR Requirements)

CLINICAL SURVEYS

As specified by Provider

THIS CIRCLE IS FOR:

Provider Receiving CMS Reimbursement For TKAs

CMS will soon penalize providers performing total knee replacements which do not collect specified outcomes data from at least 50% of qualifying patients.

Other Providers Performing TKAs

Private insurance companies and other payers within and outside the U.S. will follow the CMS lead in requiring high patient compliance in reporting long-term TKA outcomes.

WHY CIRCLES

Patented technology
HIPAA, GDPR, GCP and Part 11 compliant
Multilingual
Scalable
Easily export to, integrate with, existing systems
Robust reporting functions
Illustrative Materials
Minimal administrative and clinical burden
Accommodates surgical variations
All data accessible 24/7 from any device
Allows extensive customization
Inherent collaboration among peers
Improves clinical decision-making
Adjustable outcomes alerts
Regular reports on key metrics
Automatic patient consent capture
Illustrative Materials
Sustained onboarding and follow-up processes
Communication of condition and protocol education materials *
Regular progress reports *
Cohort comparisons *
Newsletters, other patient communications *
*  Provider defined
Illustrative Materials
Clear ownership of validated anonymized datasets
Copyrightable
Right to publish
Right to monetize
Illustrative Materials
Not a point solution, but a strategic initiative
Easily extensible and scalable
Accommodates Health Equity initiatives
Accommodates CMS Hospital Value Program and other Value-Based Care initiatives
Clinical Grade
Patented technology
HIPAA, GDPR, GCP and Part 11 compliant
Multilingual
Scalable
Robust reporting functions
Easily export to, integrate with, existing systems
Interested in this Circle?

If you have any questions, please contact us.

ADDITIONAL RESOURCES